Diets, Lipoproteins and Inflammation Markers
- Conditions
- Diet, HealthyVegan DietInflammatory ResponseCardiovascular DiseasesMetabolic Syndrome
- Interventions
- Behavioral: Vegan diet
- Registration Number
- NCT05423457
- Lead Sponsor
- Buddhist Tzu Chi General Hospital
- Brief Summary
Systematic inflammation and lipid profiles are two major therapeutic targets for cardiovascular diseases. The effectiveness of vegan diet has been reported (doi: 10.3389/fnut.2022.807810).
Aim:
To compare the effectiveness of a nutritionally balanced vegan diet and a Myplate diet ((Taiwanese version) on systematic inflammation and lipoprotein subclass.
Design: Randomized crossover design
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 21
Patients with dyslipidemia (at least one of the following)
- TG ≥ 150 mg/dL
- TC ≥ 200 mg/dL
- LDL-c≥ 130 mg/dL,
- HDL-c < 45 mg/dL for male or < 55 mg/dL for female or receiving statin treatment
Exclusion Criteria (fulfill one of the following condition):
- chronic kidney disease
- history of coronary artery disease
- ischemic heart disease,
- heart failure,
- stroke,
- cancer of any type
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Arm && Interventions
Group Intervention Description Vegan diet Vegan diet Participants were provided with and instructed to eat these foods: * flaxseed meal, * walnuts, * pecans, * extra-virgin olive oil, * Brazil nuts * Taiwanese purple laver (also known as "hong-mao-tai" or Bangia atropurpurea, and was selected to test for its vitamin B12 bioavailability). Each Participant has three group sessions and three individual nutrition counseling with a dietitian. MyPlate (Taiwanese version) Vegan diet Each Participant has three group sessions and three individual nutrition counseling with a dietitian.
- Primary Outcome Measures
Name Time Method lipoprotein particles size 12 weeks lipoprotein particles size (nm)
Traditional cadiometabolic risk factors 1 12 weeks TG(mg/dL), LDL-C(mg/dL), HDL-C(mg/dL), Total cholesterol(mg/dL)
Novel inflammatory markers for cardiovascular disease and Lipoprotein particles concentration 12 weeks GlycA (umol/L), lipoprotein particles concentration(umol/L)
Lipoprotein particles concentration 12 weeks lipoprotein particles concentration (nmol/L)
Trimethylamine-N-oxide 12 weeks TMAO (uM). TMAO is a low molecular weight compound that belongs to the class of amine oxides
Traditional cadiometabolic risk factors 3 12 weeks HOMA-IR index (Homeostasis Model Assessment-Insulin Resistance index)
Traditional cadiometabolic risk factors 2 12 weeks HbA1c(%)
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Hualien Tzu Chi Hospital
🇨🇳Hualien City, Taiwan